1
|
Furtunescu F, Bohiltea RE, Voinea S,
Georgescu TA, Munteanu O, Neacsu A and Pop CS: Breast cancer
mortality gaps in Romanian women compared to the EU after 10 years
of accession: Is breast cancer screening a priority for action in
Romania? (Review of the Statistics). Exp Ther Med.
21(268)2021.PubMed/NCBI View Article : Google Scholar
|
2
|
Brom L, Pasman HR, Widdershoven GA, van
der Vorst MJ, Reijneveld JC, Postma TJ and Onwuteaka-Philipsen BD:
Patients' preferences for participation in treatment
decision-making at the end of life: Qualitative interviews with
advanced cancer patients. PLoS One. 9(e100435)2014.PubMed/NCBI View Article : Google Scholar
|
3
|
Momenimovahed Z and Salehiniya H:
Epidemiological characteristics of and risk factors for breast
cancer in the world. Breast Cancer (Dove Med Press). 11:151–164.
2019.PubMed/NCBI View Article : Google Scholar
|
4
|
Rummel S, Hueman MT, Costantino N, Shriver
CD and Ellsworth RE: Tumor location within the breast: Does tumour
site have prognostic ability? Ecancermedicalscience.
9(552)2015.PubMed/NCBI View Article : Google Scholar
|
5
|
Caplan L: Delay in breast cancer:
Implications for stage at diagnosis and survival. Front Public
Health. 2(87)2014.PubMed/NCBI View Article : Google Scholar
|
6
|
Ben Fatma L, Belaid I, Said N, Gahbiche S,
Hochlef M, Chabchoub I, Ezzairi F and Ben Ahmed S: What could be
the reasons of late diagnosis of breast cancer in Tunisia? Tunis
Med. 96:665–671. 2018.PubMed/NCBI
|
7
|
Hegde V, Burke ZDC, Park HY, Zoller SD,
Johansen D, Kelley BV, Levine B, Motamedi K, Federman NC, Seeger
LL, et al: Is core needle biopsy reliable in differentiating
between aggressive benign and malignant radiolucent bone tumors?
Clin Orthop Relat Res. 476:568–577. 2018.PubMed/NCBI View Article : Google Scholar
|
8
|
Zhang YJ, Wei L, Li J, Zheng YQ and Li XR:
Status quo and development trend of breast biopsy technology. Gland
Surg. 2:15–24. 2013.PubMed/NCBI View Article : Google Scholar
|
9
|
Bick U, Trimboli RM, Athanasiou A,
Balleyguier C, Baltzer PAT, Bernathova M, Borbély K, Brkljacic B,
Carbonaro LA, Clauser P, et al: Image-guided breast biopsy and
localisation: Recommendations for information to women and
referring physicians by the European society of breast imaging.
Insights Imaging. 11(12)2020.PubMed/NCBI View Article : Google Scholar
|
10
|
Hanby AM: The pathology of breast cancer
and the role of the histopathology laboratory. Clin Oncol (R Coll
Radiol). 17:234–239. 2005.PubMed/NCBI View Article : Google Scholar
|
11
|
Makki J: Diversity of breast carcinoma:
Histological subtypes and clinical relevance. Clin Med Insights
Pathol. 8:23–31. 2015.PubMed/NCBI View Article : Google Scholar
|
12
|
Masood S: Neoadjuvant chemotherapy in
breast cancers. Womens Health (Lond). 12:480–491. 2016.PubMed/NCBI View Article : Google Scholar
|
13
|
Feigenberg Z, Zer M and Dintsman M:
Comparison of postoperative complications following radical and
modified radical mastectomy. World J Surg. 2:207–211.
1977.PubMed/NCBI View Article : Google Scholar
|
14
|
Morris CR, Cohen R, Schlag R and Wright
WE: Increasing trends in the use of breast-conserving surgery in
California. Am J Public Health. 90:281–284. 2000.PubMed/NCBI View Article : Google Scholar
|
15
|
Nechuta S, Lu W, Zheng Y, Cai H, Bao PP,
Gu K, Zheng W and Shu XO: Comorbidities and breast cancer survival:
A report from the Shanghai breast cancer survival study. Breast
Cancer Res Treat. 139:227–235. 2013.PubMed/NCBI View Article : Google Scholar
|
16
|
Rizvi FH, Khan MK, Almas T, Ullah M, Shafi
A, Murad MF, Ali A and Nadeem F: Early postoperative outcomes of
breast cancer surgery in a developing country. Cureus.
12(e9941)2020.PubMed/NCBI View Article : Google Scholar
|
17
|
Hu C, Song H, Wang L, Jin L, Zhou X and
Sun L: Clinical efficacy of anesthesia with intensive care nursing
in attenuating postoperative complications in patients with breast
cancer. J Int Med Res. 48(300060520930856)2020.PubMed/NCBI View Article : Google Scholar
|
18
|
Vishwakarma M and Sahani IS: Comparative
study of complications of modified radical mastectomy and breast
conservation therapy in early invasive breast cancer. Int J Surg
Sci. 3:1–3. 2019.
|
19
|
Jagsi R, Abrahamse P, Morrow M, Hawley ST,
Griggs JJ, Graff JJ, Hamilton AS and Katz SJ: Patterns and
correlates of adjuvant radiotherapy receipt after lumpectomy and
after mastectomy for breast cancer. J Clin Oncol. 28:2396–2403.
2010.PubMed/NCBI View Article : Google Scholar
|
20
|
Wöckel A, Wolters R, Wiegel T,
Novopashenny I, Janni W, Kreienberg R, Wischnewsky M and Schwentner
L: BRENDA study group. The impact of adjuvant radiotherapy on the
survival of primary breast cancer patients: A retrospective
multicenter cohort study of 8935 subjects. Ann Oncol. 25:628–632.
2014.PubMed/NCBI View Article : Google Scholar
|
21
|
Matuschek C, Bölke E, Haussmann J,
Mohrmann S, Nestle-Krämling C, Gerber PA, Corradini S, Orth K,
Kammers K and Budach W: The benefit of adjuvant radiotherapy after
breast conserving surgery in older patients with low risk breast
cancer-a meta-analysis of randomized trias. Radiat Oncol.
12(60)2017.PubMed/NCBI View Article : Google Scholar
|
22
|
Han W, Kim SW, Park IA, Kang D, Kim SW,
Youn YK, Oh SK, Choe KJ and Noh DY: Young age: An independent risk
factor for disease-free survival in women with operable breast
cancer. BMC Cancer. 4(82)2004.PubMed/NCBI View Article : Google Scholar
|
23
|
Rhiem K, Engel C, Graeser M, Zachariae S,
Kast K, Kiechle M, Ditsch N, Janni W, Mundhenke C, Golatta M, et
al: The risk of contralateral breast cancer in patients from
BRCA1/2 negative high risk families as compared to patients from
BRCA1 or BRCA2 positive families: A retrospective cohort study.
Breast Cancer Res. 14(R156)2012.PubMed/NCBI View
Article : Google Scholar
|
24
|
Untch M, Konecny GE, Paepke S and von
Minckwitz G: Current and future role of neoadjuvant therapy for
breast cancer. Breast. 23:526–537. 2014.PubMed/NCBI View Article : Google Scholar
|
25
|
Apesteguía L and Pina LJ:
Ultrasound-guided core-needle biopsy of breast lesions. Insights
Imaging. 2:493–500. 2011.PubMed/NCBI View Article : Google Scholar
|
26
|
Perry N, Broeders M, de Wolf C, Törnberg
S, Holland R and von Karsa L (eds): European guidelines for quality
assurance in breast cancer screening and diagnosis. 4th edition.
European Commission, Office for official publications of the
European communities, Luxembourg, 2006. https://screening.iarc.fr/doc/ND7306954ENC_002.pdf.
Accessed July 1, 2020.
|
27
|
Pantelimon I, Gales LN, Zgura A,
Serbanescu GL, Georgescu DE, Nita I, Manolescu LSC, Stancu AM,
Gruia MI, Anghel RM and Badiu DC: Analysis of oxidative stress in
patients with breast cancer and obesity. Ann Med Health Sci Res.
11:1578–1585. 2021.
|
28
|
Ardeleanu V, Georgescu C, Frincu LD,
Frincu LL and Vesa C: Angiogenesis as prospective molecular biology
technique for cancer study. Rom Biotech Lett. 19:9637–9648.
2014.
|
29
|
Williams SL, Birdsong GG, Cohen C and
Siddiqui MT: Immunohistochemical detection of estrogen and
progesterone receptor and HER2 expression in breast carcinomas:
Comparison of cell block and tissue block preparations. Int J Clin
Exp Pathol. 2:476–480. 2009.PubMed/NCBI
|
30
|
Sleightholm R, Neilsen BK, Elkhatib S,
Flores L, Dukkipati S, Zhao R, Choudhury S, Gardner B, Carmichael
J, Smith L, et al: Percentage of hormone receptor positivity in
breast cancer provides prognostic value: A single-institute study.
J Clin Med Res. 13:9–19. 2021.PubMed/NCBI View Article : Google Scholar
|
31
|
Bacinschi XE, Zgura A, Safta I and Anghel
R: Biomolecular factors represented by Bcl-2, p53, and
tumor-infiltrating lymphocytes predict response for adjuvant
anthracycline chemotherapy in patients with early triple-negative
breast cancer. Cancer Manag Res. 12:11965–11971. 2020.PubMed/NCBI View Article : Google Scholar
|
32
|
El Sayed R, El Jamal L, El Iskandarani S,
Kort J, Abdel Salam M and Assi H: Endocrine and targeted therapy
for hormone-receptor-positive, HER2-negative advanced breast
cancer: Insights to sequencing treatment and overcoming resistance
based on clinical trials. Front Oncol. 9(510)2019.PubMed/NCBI View Article : Google Scholar
|
33
|
Mehrgou A and Akouchekian M: The
importance of BRCA1 and BRCA2 genes mutations in breast cancer
development. Med J Islam Repub Iran. 30(369)2016.PubMed/NCBI
|
34
|
Mehedintu C, Bratila E, Berceanu C,
Cirstoiu MM, Barac RI, Andreescu CV, Badiu DC, Gales L, Zgura A and
Bumbu AG: Comparison of tumor-infiltrating lymphocytes between
primary and metastatic tumors in Her2+ and HER2-breast cancer
patients. Rev Chim. 69:3133–3137. 2018.
|
35
|
Yalagachin G, Lakshmikantha N and Mashal
SB: Prevalence of nodular goiter in patients with breast diseases.
J Clin Invest Surg. 5:91–95. 2020.
|
36
|
Mehrabani D and Manafi A: Breast implants
and breast cancer. World J Plast Surg. 1:62–63. 2012.PubMed/NCBI
|
37
|
Rostas JW and Dyess DL: Current operative
management of breast cancer: An age of smaller resections and
bigger cures. Int J Breast Cancer. 2012(516417)2012.PubMed/NCBI View Article : Google Scholar
|
38
|
Franceschini G, Di Leone A, Natale M,
Sanchez MA and Masett R: Conservative surgery after neoadjuvant
chemotherapy in patients with operable breast cancer. Ann Ital
Chir. 89(290)2018.PubMed/NCBI
|
39
|
van Oers H and Schlebusch L: Indicators of
psychological distress and body image disorders in female patients
with breast cancer. J Mind Med Sci. 7:179–187. 2020.
|
40
|
White J, Achuthan R, Turton P and Lansdown
M: Breast conservation surgery: State of the art. Int J Breast
Cancer. 2011(107981)2011.PubMed/NCBI View Article : Google Scholar
|
41
|
Ursaru M, Jari I, Negru D and Scripcariu
V: Local and distant recurrences-a comparative study on
conservative and radical surgery for breast cancer. Chirurgia
(Bucur). 110:38–42. 2015.PubMed/NCBI
|
42
|
Veronesi U, Cascinelli N, Mariani L, Greco
M, Saccozzi R, Luini A, Aguilar M and Marubini E: Twenty-year
follow-up of a randomized study comparing breast-conserving surgery
with radical mastectomy for early breast cancer. N Engl J Med.
347:1227–1232. 2002.PubMed/NCBI View Article : Google Scholar
|